We successfully performed microaerobic fermentation of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural physiological condition of human gut microbiome, using BioFlo® 120 and 320 control stations.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Microaerobic Fermentation of Lactobacillus acidophilus
Related Resources
Discover the world of upstream bioprocessing
A must-read for all bioprocess scientists: This bundle of four ebooks created by Eppendorf guides you through the world of upstream bioprocessing.
Manufacturing of hiPSC-Derived Cardiomyocytes
Effective drug discovery and development relies on the availability of predictive preclinical model systems. Technologies based on human induced pluripotent stem cells (hiPSC) hold great promise to overcome this challenge. In this application note...
Supplier Info Centre
For more product information visit Eppendorf Bioprocess Solutions.